• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

难治性儿童克罗恩病的药物治疗

Medical therapy for refractory pediatric Crohn's disease.

作者信息

Faubion William A, Bousvaros Athos

机构信息

Division of Pediatric Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.

出版信息

Clin Gastroenterol Hepatol. 2006 Oct;4(10):1199-213. doi: 10.1016/j.cgh.2006.05.031. Epub 2006 Jul 26.

DOI:10.1016/j.cgh.2006.05.031
PMID:16872913
Abstract

Crohn's disease is a common indication for referral to pediatric gastroenterology. While most patients with Crohn's disease respond to standard induction therapy, steroid-refractory or steroid-dependent disease is a frequently encountered problem. This review discusses the data existing in both the adult and pediatric literature for medical therapy of refractory pediatric Crohn's disease.

摘要

克罗恩病是转诊至儿科胃肠病学的常见指征。虽然大多数克罗恩病患者对标准诱导疗法有反应,但激素难治性或激素依赖性疾病是一个经常遇到的问题。本综述讨论了成人和儿科文献中关于难治性儿科克罗恩病药物治疗的现有数据。

相似文献

1
Medical therapy for refractory pediatric Crohn's disease.难治性儿童克罗恩病的药物治疗
Clin Gastroenterol Hepatol. 2006 Oct;4(10):1199-213. doi: 10.1016/j.cgh.2006.05.031. Epub 2006 Jul 26.
2
Review article: Medical therapy for fistulizing Crohn's disease.综述文章:瘘管性克罗恩病的药物治疗
Aliment Pharmacol Ther. 2006 Nov 1;24(9):1283-93. doi: 10.1111/j.1365-2036.2006.03126.x.
3
Managing complicated Crohn's disease in children and adolescents.儿童及青少年复杂性克罗恩病的管理
Nat Clin Pract Gastroenterol Hepatol. 2005 Dec;2(12):572-9. doi: 10.1038/ncpgasthep0338.
4
Long-term partial remission of autoimmune thrombocytopenia in a patient treated with the anti-tumor necrosis factor-alpha antibody infliximab for refractory fistulizing Crohn's disease.一名患有难治性瘘管性克罗恩病的患者,使用抗肿瘤坏死因子-α抗体英夫利昔单抗治疗后,自身免疫性血小板减少症获得长期部分缓解。
Digestion. 2008;78(4):195-200. doi: 10.1159/000187637. Epub 2008 Dec 22.
5
The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease.意大利胃肠病学会(SIGE)和意大利炎症性肠病研究组(IG-IBD)临床实践指南:肿瘤坏死因子-α拮抗剂在炎症性肠病中的应用。
Dig Liver Dis. 2011 Jan;43(1):1-20. doi: 10.1016/j.dld.2010.07.010. Epub 2010 Sep 16.
6
Review article: Altering the natural history of Crohn's disease--evidence for and against current therapies.综述文章:改变克罗恩病的自然病程——支持和反对当前疗法的证据
Aliment Pharmacol Ther. 2007 Jan 1;25(1):3-12. doi: 10.1111/j.1365-2036.2006.03134.x.
7
Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease.肿瘤坏死因子-α拮抗剂可改善克罗恩病患者的内皮功能障碍。
Clin Pharmacol Ther. 2008 Jan;83(1):70-6. doi: 10.1038/sj.clpt.6100229. Epub 2007 May 16.
8
Treatment of vulval Crohn's disease with infliximab.英夫利昔单抗治疗外阴克罗恩病
Clin Exp Dermatol. 2006 May;31(3):378-80. doi: 10.1111/j.1365-2230.2006.02079.x.
9
Infliximab in fistulizing Crohn's disease.英夫利昔单抗治疗瘘管型克罗恩病
Gastroenterol Clin North Am. 2006 Dec;35(4):795-820. doi: 10.1016/j.gtc.2006.09.007.
10
Clinical perspectives in Crohn's disease. Moving forward with anti-TNF-alpha therapy: current needs and future treatments.克罗恩病的临床展望。抗肿瘤坏死因子-α治疗的进展:当前需求与未来治疗方法
Rev Gastroenterol Disord. 2007;7 Suppl 2:S23-35.